DATABASE

Name	Category
CytRx Announces the Presentation of Favorable Results from Novel Combination of Aldoxorubicin and Doxorubicin in a Phase 1b Clinical Trial at ASCO Con	News
CYTRX CORP Files SEC form 10-Q, Quarterly Report	News
CYTRX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits	News
CYTRX CORP Financials	News
CytRx Corporation	Fund
CytRx Issues Letter to Stockholders Providing Business Update	News
CytRx Provides Update on Clinical Programs	News
CytRx re-initiated with a Buy at Roth Capital	News
CytRx Receives Recommendation from Data Safety Monitoring Committee to Complete International Phase 2b Trial with Aldoxorubicin as First-Line Treatmen	News
CytRx Reports 2013 First Quarter Financial Results	News
CytRx to Present at the Marcum MicroCap Conference	News
Cytta Completes Mobile Monitoring Technology Pilot Program and Begins Licensing Discussions	News
Cytta Corp.	Fund
CYTTA CORP. Files SEC form 10-Q, Quarterly Report	News
CYTTA CORP. Financials	News
Czamarka Gustavo	Contact
Czamarka Gustavo	Contact
Czech Billionaire Vitek Targets Assets in Central Europe	News
Czech Billionaire Vitek Targets Assets in Central Europe	News
Czech capital on alert as floods sweep central Europe	News
Czech capital on alert as floods sweep central Europe	News
Czech developer Orco posts loss, revenues up on property sales	News
Czech Energy Holding, A.s.	Bank
Czech Rainfall Threatens Prague With Flooding, Railway Closures	News
Czech(Rep Of) 2.75%	Company

Page 1069 of 1069